Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (855)	3/13/2000 8:33:00 AM
From: Carole	Read Replies (2) \| Respond to of 1018

Wow... this approval will really broaden the market for IFLO~! Monday March 13, 8:09 am Eastern Time Company Press Release I-Flow Corporation Receives Permission to Market 5-Inch Pain Management Soaker Catheter LAKE FOREST, Calif.--(BUSINESS WIRE)--March 13, 2000--I-Flow Corporation (Nasdaq:IFLO - news) announced today that the U.S. Food and Drug Administration (FDA) has granted the Company permission to market its new 5-inch Soaker(TM) Catheter for pain management of large surgical incisions. ``I-Flow's 5-inch Soaker Catheter, in contrast to the 2 1/2-inch version for smaller surgical incisions, provides a continuous infusion of a non-narcotic, local anesthetic directly across long incisions for post operative pain management for such surgeries as hysterectomies, C-sections and open-heart procedures,' said Chairman, President and Chief Executive Officer Donald M. Earhart. ``This new Soaker Catheter, which distributes fluid in a similar manner to the way a soaker hose saturates a lawn, is expected to be distributed by I-Flow and its surgical partners,' he said. The CEO explained that the Soaker Catheter, which attaches to I-Flow's ON-Q(TM) and PainBuster(TM) pain management systems, is enclosed in the wound site at the completion of the surgery and is removed two to five days later. Earhart said, ``With the Soaker Catheter we believe that there is the potential for better pain management of surgical procedures requiring large incisions without the undesirable side effects of narcotic pain relievers. In addition to its pain management benefits, we are exploring other therapeutic applications for this infusion technology.' Noting that I-Flow's 2 1/2-inch Soaker Catheter was cleared by the FDA in November 1999, Earhart said that the 5-inch version reflects the continuing evolution of I-Flow's product lines. ``This new catheter is an important addition to our pain management product family, which includes the PainBuster, ON-Q, Nerve Block(TM) Infusion Kit and Paragon(TM) products. The Soaker Catheter technology is a significant advancement in wound site therapeutics and is an excellent platform for I-Flow's future pain management product innovations for the more than 39 million annual surgical procedures in the United States,' he explained. biz.yahoo.com